{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T19:44:09Z","timestamp":1759693449892,"version":"3.44.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100006135","name":"ERAB: The European Foundation for Alcohol Research","doi-asserted-by":"publisher","award":["202213","EA1840"],"award-info":[{"award-number":["202213","EA1840"]}],"id":[{"id":"10.13039\/501100006135","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.ejphar.2022.175088","type":"journal-article","created":{"date-parts":[[2022,6,8]],"date-time":"2022-06-08T11:21:44Z","timestamp":1654687304000},"page":"175088","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["The multitarget FAAH inhibitor\/D3 partial agonist ARN15381 decreases nicotine self-administration in male rats"],"prefix":"10.1016","volume":"928","author":[{"given":"Veronica","family":"Lunerti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongwu","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federica","family":"Benvenuti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qianwei","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Domi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Soverchia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2287-3331","authenticated-orcid":false,"given":"Rita Maria","family":"Concetta Di Martino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1251-583X","authenticated-orcid":false,"given":"Giovanni","family":"Bottegoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolina L.","family":"Haass-Koffler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2891-8679","authenticated-orcid":false,"given":"Nazzareno","family":"Cannella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2022.175088_bib1","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/BF01959874","article-title":"The plasma volume of the Wistar rat in relation to the body weight","volume":"37","author":"Bijsterbosch","year":"1981","journal-title":"Experientia"},{"key":"10.1016\/j.ejphar.2022.175088_bib2","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/BF00589894","article-title":"Nicotine maintains robust self-administration in rats on a limited-access schedule","volume":"99","author":"Corrigall","year":"1989","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.ejphar.2022.175088_bib3","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1021\/acs.jmedchem.6b01578","article-title":"Design, synthesis, structure-activity relationship studies, and three-dimensional quantitative structure-activity relationship (3D-QSAR) modeling of a series of O-biphenyl carbamates as dual modulators of dopamine D3 receptor and fatty acid amide hydrolase","volume":"60","author":"De Simone","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2022.175088_bib4","doi-asserted-by":"crossref","first-page":"5274","DOI":"10.1073\/pnas.85.14.5274","article-title":"Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats","volume":"85","author":"Di Chiara","year":"1988","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejphar.2022.175088_bib5","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1124\/jpet.104.078980","article-title":"Characterization of the fatty acid amide hydrolase inhibitor cyclohexyl carbamic acid 3'-carbamoyl-biphenyl-3-yl ester (URB597): effects on anandamide and oleoylethanolamide deactivation","volume":"313","author":"Fegley","year":"2005","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejphar.2022.175088_bib6","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.physbeh.2017.11.017","article-title":"Sex differences in nicotine intravenous self-administration: a meta-analytic review","volume":"203","author":"Flores","year":"2019","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.ejphar.2022.175088_bib7","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s00213-009-1569-5","article-title":"Inhibition of fatty acid amide hydrolase reduces reinstatement of nicotine seeking but not break point for nicotine self-administration--comparison with CB(1) receptor blockade","volume":"205","author":"Forget","year":"2009","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.ejphar.2022.175088_bib8","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/npp.2016.176","article-title":"Individual variations in the mechanisms of nicotine seeking: a key for research on nicotine dependence","volume":"42","author":"Garcia-Rivas","year":"2017","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejphar.2022.175088_bib9","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/adb.12607","article-title":"Not all smokers appear to seek nicotine for the same reasons: implications for preclinical research in nicotine dependence","volume":"24","author":"Garcia-Rivas","year":"2019","journal-title":"Addiction Biol."},{"key":"10.1016\/j.ejphar.2022.175088_bib10","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0083-6729(09)81010-8","article-title":"Modulation of the endocannabinoid-degrading enzyme fatty acid amide hydrolase by follicle-stimulating hormone","volume":"81","author":"Grimaldi","year":"2009","journal-title":"Vitam. Horm."},{"key":"10.1016\/j.ejphar.2022.175088_bib11","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/0165-6147(93)90129-8","article-title":"Partial agonists, full agonists, antagonists: dilemmas of definition","volume":"14","author":"Hoyer","year":"1993","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ejphar.2022.175088_bib12","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/0014-2999(86)90629-1","article-title":"Nicotine preferentially stimulates dopamine release in the limbic system of freely moving rats","volume":"132","author":"Imperato","year":"1986","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2022.175088_bib13","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1038\/npp.2015.62","article-title":"Effects of fatty acid amide hydrolase (FAAH) inhibitors in non-human primate models of nicotine reward and relapse","volume":"40","author":"Justinova","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejphar.2022.175088_bib14","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s00213-004-2021-5","article-title":"Nicotine induces conditioned place preferences over a large range of doses in rats","volume":"178","author":"Le Foll","year":"2005","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.ejphar.2022.175088_bib15","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s00213-005-0155-8","article-title":"Nicotine as a typical drug of abuse in experimental animals and humans","volume":"184","author":"Le Foll","year":"2006","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.ejphar.2022.175088_bib16","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1517\/13543784.16.1.45","article-title":"Dopamine D3 receptor ligands for the treatment of tobacco dependence","volume":"16","author":"Le Foll","year":"2007","journal-title":"Expet Opin. Invest. Drugs"},{"key":"10.1016\/j.ejphar.2022.175088_bib17","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1038\/sj.npp.1300622","article-title":"Dopamine D3 receptor ligands block nicotine-induced conditioned place preferences through a mechanism that does not involve discriminative-stimulus or antidepressant-like effects","volume":"30","author":"Le Foll","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejphar.2022.175088_bib18","first-page":"72","article-title":"Blood volume in the rat","volume":"26","author":"Lee","year":"1985","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.ejphar.2022.175088_bib19","doi-asserted-by":"crossref","first-page":"8155","DOI":"10.1073\/pnas.89.17.8155","article-title":"Identification, characterization, and localization of the dopamine D3 receptor in rat brain using 7-[3H]hydroxy-N,N-di-n-propyl-2-aminotetralin","volume":"89","author":"Levesque","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejphar.2022.175088_bib20","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1369-1600.2010.00222.x","article-title":"Effects of fatty acid amide hydrolase inhibition on neuronal responses to nicotine, cocaine and morphine in the nucleus accumbens shell and ventral tegmental area: involvement of PPAR-alpha nuclear receptors","volume":"15","author":"Luchicchi","year":"2010","journal-title":"Addiction Biol."},{"key":"10.1016\/j.ejphar.2022.175088_bib21","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.neuron.2006.05.007","article-title":"Hierarchical control of dopamine neuron-firing patterns by nicotinic receptors","volume":"50","author":"Mameli-Engvall","year":"2006","journal-title":"Neuron"},{"key":"10.1016\/j.ejphar.2022.175088_bib22","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1124\/jpet.109.165084","article-title":"Characterization of the transport, metabolism, and pharmacokinetics of the dopamine D3 receptor-selective fluorenyl- and 2-pyridylphenyl amides developed for treatment of psychostimulant abuse","volume":"333","author":"Mason","year":"2010","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejphar.2022.175088_bib23","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.biopsych.2010.04.016","article-title":"Peroxisome proliferator-activated receptors-alpha modulate dopamine cell activity through nicotinic receptors","volume":"68","author":"Melis","year":"2010","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.ejphar.2022.175088_bib24","doi-asserted-by":"crossref","first-page":"13985","DOI":"10.1523\/JNEUROSCI.3221-08.2008","article-title":"Endogenous fatty acid ethanolamides suppress nicotine-induced activation of mesolimbic dopamine neurons through nuclear receptors","volume":"28","author":"Melis","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2022.175088_bib25","doi-asserted-by":"crossref","first-page":"3276","DOI":"10.1098\/rstb.2011.0383","article-title":"Hub and switches: endocannabinoid signalling in midbrain dopamine neurons","volume":"367","author":"Melis","year":"2012","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"key":"10.1016\/j.ejphar.2022.175088_bib26","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1124\/mol.106.023044","article-title":"alpha4beta2 nicotinic receptors with high and low acetylcholine sensitivity: pharmacology, stoichiometry, and sensitivity to long-term exposure to nicotine","volume":"70","author":"Moroni","year":"2006","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejphar.2022.175088_bib27","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.lfs.2012.05.015","article-title":"The role of fatty acid amide hydrolase inhibition in nicotine reward and dependence","volume":"92","author":"Muldoon","year":"2013","journal-title":"Life Sci."},{"key":"10.1016\/j.ejphar.2022.175088_bib28","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1016\/S0960-894X(03)00389-5","article-title":"N-(4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butyl, butenyl and butynyl)arylcarboxamides as novel dopamine D(3) receptor antagonists","volume":"13","author":"Newman","year":"2003","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejphar.2022.175088_bib29","doi-asserted-by":"crossref","DOI":"10.1093\/ijnp\/pyw074","article-title":"Cigarette use and striatal dopamine D2\/3 receptors: possible role in the link between smoking and nicotine dependence","volume":"19","author":"Okita","year":"2016","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.ejphar.2022.175088_bib30","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1017\/S1461145706006560","article-title":"The selective dopamine D3 receptor antagonist SB-277011A reduces nicotine-enhanced brain reward and nicotine-paired environmental cue functions","volume":"9","author":"Pak","year":"2006","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.ejphar.2022.175088_bib31","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.pharmthera.2013.01.003","article-title":"Inhibition of FAAH and activation of PPAR: new approaches to the treatment of cognitive dysfunction and drug addiction","volume":"138","author":"Panlilio","year":"2013","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2022.175088_bib32","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1111\/adb.12531","article-title":"Fatty acid amide hydrolase (FAAH) inactivation confers enhanced sensitivity to nicotine-induced dopamine release in the mouse nucleus accumbens","volume":"23","author":"Pavon","year":"2018","journal-title":"Addiction Biol."},{"key":"10.1016\/j.ejphar.2022.175088_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2022.104584","article-title":"Regulation of cocaine-related behaviours by estrogen and progesterone","volume":"135","author":"Peart","year":"2022","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.ejphar.2022.175088_bib34","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1093\/alcalc\/agh110","article-title":"The endocannabinoid system: physiology and pharmacology","volume":"40","author":"Rodriguez de Fonseca","year":"2005","journal-title":"Alcohol Alcohol"},{"key":"10.1016\/j.ejphar.2022.175088_bib35","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ejphar.2007.01.004","article-title":"Effects of the selective dopamine D3 receptor antagonist SB-277011A on the reinforcing effects of nicotine as measured by a progressive-ratio schedule in rats","volume":"559","author":"Ross","year":"2007","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2022.175088_bib36","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1007\/s00213-015-4196-3","article-title":"Interactions between the endocannabinoid and nicotinic cholinergic systems: preclinical evidence and therapeutic perspectives","volume":"233","author":"Scherma","year":"2016","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.ejphar.2022.175088_bib37","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1124\/jpet.108.142224","article-title":"Inhibition of anandamide hydrolysis by cyclohexyl carbamic acid 3'-carbamoyl-3-yl ester (URB597) reverses abuse-related behavioral and neurochemical effects of nicotine in rats","volume":"327","author":"Scherma","year":"2008","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejphar.2022.175088_bib38","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/ejn.13390","article-title":"The dopamine D3 receptor, a quarter century later","volume":"45","author":"Sokoloff","year":"2017","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.ejphar.2022.175088_bib39","doi-asserted-by":"crossref","first-page":"5563","DOI":"10.1523\/JNEUROSCI.5240-04.2005","article-title":"Chronic nicotine exposure upregulates nicotinic receptors by a novel mechanism","volume":"25","author":"Vallejo","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2022.175088_bib40","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/S0091-3057(98)00226-3","article-title":"Blockade of nicotine self-administration with nicotinic antagonists in rats","volume":"62","author":"Watkins","year":"1999","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejphar.2022.175088_bib41","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.neuroscience.2010.09.005","article-title":"Nicotine-induced up regulation of alpha4beta2 neuronal nicotinic receptors is mediated by the protein kinase C-dependent phosphorylation of alpha4 subunits","volume":"171","author":"Wecker","year":"2010","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejphar.2022.175088_bib42","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/aps.2009.46","article-title":"Mechanism-based medication development for the treatment of nicotine dependence","volume":"30","author":"Xi","year":"2009","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.ejphar.2022.175088_bib43","doi-asserted-by":"crossref","first-page":"83","DOI":"10.2174\/1871524914666141226103135","article-title":"Estradiol, dopamine and motivation","volume":"14","author":"Yoest","year":"2014","journal-title":"Cent. Nerv. Syst. Agents Med. Chem."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299922003491?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299922003491?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T23:02:50Z","timestamp":1757977370000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299922003491"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":43,"alternative-id":["S0014299922003491"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2022.175088","relation":{},"ISSN":["0014-2999"],"issn-type":[{"type":"print","value":"0014-2999"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The multitarget FAAH inhibitor\/D3 partial agonist ARN15381 decreases nicotine self-administration in male rats","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2022.175088","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"175088"}}